Examination Report |
1 | Additional Representation Sheet | 03 Apr 2012 |
10 | Letter | 09 Jul 2021 |
11 | Annexure | 09 Jul 2021 |
12 | Annexure | 13 Jul 2021 |
12 | Letter | 13 Jul 2021 |
13 | Annexure | 13 Jul 2021 |
13 | Letter | 13 Jul 2021 |
14 | Letter | 27 Aug 2021 |
15 | Letter | 27 Aug 2021 |
2 | General Power of Attorney | 03 Apr 2012 |
3 | TM-1 | 03 Apr 2012 |
4 | Reply to Exam Report (MIS-R) | 18 Apr 2013 |
5 | TM-5 | 10 Mar 2014 |
6 | Other Documents | 09 Sep 2015 |
7 | Agreement | 11 Dec 2015 |
8 | Agreement | 11 Dec 2015 |
9 | Letter | 18 Jan 2019 |
The application for Rozucor asp was made on 03 April 2012.
The trademark applicant for Rozucor asp is TORRENT PHARMACEUTICALS.
Rozucor asp is applied in class(es) 5.
Application for Rozucor asp is on Opposed stage.
Application Id allotted to Rozucor asp is 2309934.
Trademark agent or attorney for the application is R. R. Shah & Co.
Rozucor asp filed with the Intellectual property office as a DEVICE.